BioSpace News Archive

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies’ existing CDO partnership first established in 2018.

July 15, 2020
·
2 min read
Evox Therapeutics Expands Existing Exosome Patent Portfolio With Further Grant Covering Exosomes for RNA Therapeutics

Evox Therapeutics Ltd, a leading exosome therapeutics company, is pleased to announce that the Company has been granted a key patent by the United States Patent and Trademark Office.

July 15, 2020
·
2 min read
Deals

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

Terumo Corporation announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy, a treatment for liver tumors.

July 15, 2020
·
5 min read
Deals

Medtronic to Acquire Medicrea

Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

July 15, 2020
·
7 min read
Deals

Cytovance Biologics Announces an Investment in Mass Spectrometry Services

Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization, announces the addition of Mass Spectrometry to its Analytical Development suite of services.

July 15, 2020
·
3 min read
RaySearch and TAE Life Sciences Announce Agreement on RayStation Support for the Alphabeam System for BNCT

RaySearch Laboratories AB has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeam™ System for boron neutron capture therapy.

July 15, 2020
·
2 min read
Policy

Knopp Biosciences Receives Rare Pediatric Disease Designation for Kv7 Activator KB-3061 for Treatment of KCNQ2 Epileptic Encephalopathy

Knopp Biosciences LLC announced that it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for its therapeutic candidate KB-3061, an activator of voltage-gated Kv7.2/7.3 potassium channels, for the treatment of KCNQ2 epileptic encephalopathy.

July 15, 2020
·
4 min read
Business

West Announces Third-Quarter 2020 Dividend

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the Company’s Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.

July 15, 2020
·
1 min read
Pharm Country

New Medscape Report on Women Physicians Finds Work-Life Balance the Major Career Challenge

Stress of Balancing Personal, Professional Demands Outstrips Concerns with Compensation, Parity

July 15, 2020
·
4 min read
BioMidwest

TherapeuticsMD and Nurx Expand Access to ANNOVERA®

Largest online practice for women’s health now offers the first FDA-approved long-lasting birth control method that does not require a medical procedure

July 15, 2020
·
10 min read